Percorten-V

(℞) Prescription Required

Top Brand Choice
Top Generic Choice

Percorten-V 25mg/mL

Product of United Kingdom
Manufactured by: Dechra Pharmaceuticals
*Product image for reference use only.
🐾 Pet Medication
Select Quantity
Percorten-V 25mg/mL
Product of United Kingdom
Manufactured by Dechra Pharmaceuticals
Top Brand Choice
Top Generic Choice

Percorten-V 25mg/mL

Product of United States
Manufactured by: Novartis
*Product image for reference use only.
🐾 Pet Medication
Select Quantity
Percorten-V 25mg/mL
Product of United States
Manufactured by Novartis
Select your dosage

Percorten-V (desoxycorticosterone pivalate) Dosage and Side Effects

PET MEDICATION

Percorten-V (Desoxycorticosterone pivalate [DOCP]) is a mineralocorticoid hormone and an analog of desoxycorticosterone. It is white, odourless and stable in air. It is practically insoluble in water, sparingly soluble in acetone, slightly soluble in methanol, ether and vegetable oils.

Proper Use of this medication

Before injection, shake the vial thoroughly to mix the microcrystals with the suspension vehicle. Percorten-V [DOCP] sterile suspension is to be injected intramuscularly. Care should be used to prevent inadvertent intravenous injection, which may have adverse effects on the animal.

Side Effects

Some patients are more sensitive to the actions of Percorten-V [DOCP] and may exhibit side effects to an exaggerated degree. Some patients may show signs of hypernatremia or hypokalemia. The dosage of DOCP should be reduced in these patients.

Like other adrenocortical hormones, DOCP may cause side effects if dosage is too high or prolonged. It may cause polyuria, polydipsia, increased blood volume, edema and cardiac enlargement. Excessive weight gain may indicate fluid retention secondary to sodium retention. Percorten-V should be used with caution in patients with congestive heart disease, edema or renal disease.

On rare occasions, irritation at the site of injection has been reported.

Warnings and Precautions

Keep this and all drugs out of the reach of children. In case of human consumption, contact a physician or Poison Control centre immediately.

Interactions with this medication

Some patients are more sensitive to the actions of Percorten-V [DOCP] and may exhibit side effects to an exaggerated degree. Some patients may show signs of hypernatremia or hypokalemia. The dosage of DOCP should be reduced in these patients.

Like other adrenocortical hormones, DOCP may cause side effects if dosage is too high or prolonged. It may cause polyuria, polydipsia, increased blood volume, edema and cardiac enlargement. Excessive weight gain may indicate fluid retention secondary to sodium retention. Percorten-V should be used with caution in patients with congestive heart disease, edema or renal disease.

On rare occasions, irritation at the site of injection has been reported.

Other related products

The above information is an educational aid only. It is not intended as medical advice for individual conditions or treatments. Talk to your doctor, nurse or pharmacist before following any medical regimen to see if it is safe and effective for you.

Back to top